Early left ventricular gene expression profile in response to increase in blood pressure

Blood Pressure

Volumn 15, Issue 6, 2006, Pages 375-383

  Rysä, Jaana ^a   Aro, Jani ^a   Ruskoaho, Heikki ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Angiotensin receptor blockers; Gene expression regulation; Hypertrophy; Vasopressin

Indexed keywords

ARGININE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; COMPLEMENTARY DNA; DNA; EARLY GROWTH RESPONSE FACTOR 1; EPIDERMAL FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; HEAT SHOCK PROTEIN 70; LOSARTAN; NUCLEAR RECEPTOR NUR77; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN BCL X; UNCLASSIFIED DRUG; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE INDUCTION; GROWTH DISORDER; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HYPERTENSION; IMMEDIATE EARLY GENE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; RISK FACTOR;

ACUTE DISEASE; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ARGININE VASOPRESSIN; BCL-X PROTEIN; BLOOD PRESSURE; CELL CYCLE PROTEINS; CHRONIC DISEASE; CONSCIOUSNESS; DNA, COMPLEMENTARY; EARLY GROWTH RESPONSE PROTEIN 1; EYE PROTEINS; FATTY ACID-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART VENTRICLES; HSP70 HEAT-SHOCK PROTEINS; HYPERTENSION; LOSARTAN; MALE; NERVE GROWTH FACTOR; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 33847184240     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050601037851     Document Type: Article

References (42)

1. Lorell, B. H. and Carabello, B. A. (2000) Left ventricular hypertrophy: Pathogenesis, detection, and prognosis. Circulation, 102, pp. 470-479.
2. Sugden, P. H. and Clerk, A. (1998) Cellular mechanisms of cardiac hypertrophy. J Mol Med, 76, pp. 725-746.
3. Izumo, S., Nadal-Ginard, B. and Mahdavi, V. (1988) Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA, 85, pp. 339-343.
4. Magga, J., Marttila, M., Mantymaa, P., Vuolteenaho, O. and Ruskoaho, H. (1994) Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin- and phenylephrine-infused conscious rats. Endocrinology, 134, pp. 2505-2515.
5. Ruskoaho, H. (1992) Atrial natriuretic peptide: Synthesis, release, and metabolism. Pharmacol Rev, 44, pp. 479-602.
6. Tokola, H., Hautala, N., Marttila, M., Magga, J., Pikkarainen, S. and Kerkela, R. (2001) Mechanical load-induced alterations in B-type natriuretic peptide gene expression. Can J Physiol Pharmacol, 79, pp. 646-653.
7. Sadoshima, J. and Izumo, S. (1997) The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol, 59, pp. 551-571.
8. Romppanen, H., Puhakka, J., Foldes, G., Szokodi, I., Vuolteenaho, O. and Tokola, H. (2001) Endothelin-1-independent and angiotensin ii-independent induction of adrenomedullin gene expression. Hypertension, 37, pp. 84-90.
9. Foldes, G., Suo, M., Szokodi, I., Lako-Futo, Z., deChatel, R. and Vuolteenaho, O. (2001) Factors derived from adrenals are required for activation of cardiac gene expression in angiotensin II-induced hypertension. Endocrinology, 142, pp. 4256-4263.
10. Lako-Futo, Z., Szokodi, I., Sarman, B., Foldes, G., Tokola, H. and Ilves, M. (2003) Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart. Circulation, 108, pp. 2414-2422.
11. Rysa, J., Leskinen, H., Ilves, M. and Ruskoaho, H. (2005) Distinct upregulation of extracellular matrix genes in transition from hypertrophy to hypertensive heart failure. Hypertension, 45, pp. 927-933.
12. Yamazaki, T., Komuro, I. and Yazaki, Y. (1995) Molecular mechanism of cardiac cellular hypertrophy by mechanical stress. J Mol Cell Cardiol, 27, pp. 133-140.
13. Suo, M., Hautala, N., Foldes, G., Szokodi, I., Toth, M. and Leskinen, H. (2002) Posttranscriptional control of BNP gene expression in angiotensin II-induced hypertension. Hypertension, 39, pp. 803-808.
14. Larkin, J. E., Frank, B. C., Gaspard, R. M., Duka, I., Gavras, H. and Quackenbush, J. (2004) Cardiac transcriptional response to acute and chronic angiotensin II treatments. Physiol Genomics, 18, pp. 152-166.
15. Weinberg, E. O., Mirotsou, M., Gannon, J., Dzau, V. J., Lee, R. T. and Pratt, R. E. (2003) Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. Physiol Genomics, 12, pp. 113-127.
16. Heide, R. S. Vander (2002) Increased expression of HSP27 protects canine myocytes from simulated ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol, 282, p. H935.
17. Chen, Y., Arrigo, A. P. and Currie, R. W. (2004) Heat shock treatment suppresses angiotensin II-induced activation of NF-kappaB pathway and heart inflammation: A role for IKK depletion by heat shock?. Am J Physiol Heart Circ Physiol, 287, p. H1104.
18. Tanonaka, K., Yoshida, H., Toga, W., Furuhama, K. and Takeo, S. (2001) Myocardial heat shock proteins during the development of heart failure. Biochem Biophys Res Commun, 283, pp. 520-525.
19. Sheikh, M. S., Hollander, M. C. and Fornance Jr., A. J. (2000) Role of Gadd45 in apoptosis. Biochem Pharmacol, 59, pp. 43-45.
20. Zhan, Q., Lord, K. A., Alamo Jr., I., Hollander, M. C., Carrier, F. and Ron, D. (1994) The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol Cell Biol, 14, pp. 2361-2371.
21. Edwards, M. G., Sarkar, D., Klopp, R., Morrow, J. D., Weindruch, R. and Prolla, T. A. (2003) Age-related impairment of the transcriptional responses to oxidative stress in the mouse heart. Physiol Genomics, 13, pp. 119-127.
22. Simkhovich, B. Z., Marjoram, P., Poizat, C., Kedes, L. and Kloner, R. A. (2003) Age-related changes of cardiac gene expression following myocardial ischemia/reperfusion. Arch Biochem Biophys, 420, pp. 268-278.
23. Lin, K., Hsu, P. P., Chen, B. P., Yuan, S., Usami, S. and Shyy, J. Y. (2000) Molecular mechanism of endothelial growth arrest by laminar shear stress. Proc Natl Acad Sci USA, 97, pp. 9385-9389.
24. Takekawa, M. and Saito, H. (1998) A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/ MEKK4 MAPKKK. Cell, 95, pp. 521-530.
25. Tenhunen, O., Sarman, B., Kerkela, R., Szokodi, I., Papp, L. and Toth, M. (2004) Mitogen-activated protein kinases p38 and ERK 1/2 mediate the wall stress-induced activation of GATA-4 binding in adult heart. J Biol Chem, 279, pp. 24852-24860.
26. van Empel, V. P., Bertrand, A. T., Hofstra, L., Crijns, H. J., Doevendans, P. A. and De Windt, L. J. (2005) Myocyte apoptosis in heart failure. Cardiovasc Res, 67, pp. 21-29.
27. Valks, D. M., Kemp, T. J. and Clerk, A. (2003) Regulation of Bcl-xL expression by H2O2 in cardiac myocytes. J Biol Chem, 278, pp. 25542-25547.
28. Boise, L. H., Gonzalez-Garcia, M., Postema, C. E., Ding, L., Lindsten, T. and Turka, L. A. (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, pp. 597-608.
29. Hertzel, A. V. and Bernlohr, D. A. (2000) The mammalian fatty acid-binding protein multigene family: Molecular and genetic insights into function. Trends Endocrinol Metab, 11, pp. 175-180.
30. Owada, Y., Utsunomiya, A., Yoshimoto, T. and Kondo, H. (1997) Changes in gene expression for skin-type fatty acid binding protein in hypoglossal motor neurons following nerve crush. Neurosci Lett, 223, pp. 25-28.
31. De Leon, M., Welcher, A. A., Nahin, R. H., Liu, Y., Ruda, M. A. and Shooter, E. M. (1996) Fatty acid binding protein is induced in neurons of the dorsal root ganglia after peripheral nerve injury. J Neurosci Res, 44, pp. 283-292.
32. Makowski, L., Boord, J. B., Maeda, K., Babaev, V. R., Uysal, K. T. and Morgan, M. A. (2001) Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med, 7, pp. 699-705.
33. Prinsen, C. F. and Veerkamp, J. H. (1998) Transfection of L6 myoblasts with adipocyte fatty acid-binding protein cDNA does not affect fatty acid uptake but disturbs lipid metabolism and fusion. Biochem J, 329, pp. 265-273.
34. Kudo, I. and Murakami, M. (2002) Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat, 68, pp. 3-58.
35. Haq, S., Kilter, H., Michael, A., Tao, J., O'Leary, E. and Sun, X. M. (2003) Deletion of cytosolic phospholipase A2 promotes striated muscle growth. Nat Med, 9, pp. 944-951.
36. Aoki, J., Nagai, Y., Hosono, H., Inoue, K. and Arai, H. (2002) Structure and function of phosphatidylserine-specific phospholipase A1. Biochim Biophys Acta, 1582, pp. 26-32.
37. Sudhof, T. C. (2001) alpha-Latrotoxin and its receptors: Neurexins and CIRL/latrophilins. Annu Rev Neurosci, 24, pp. 933-962.
38. + exchangers. Physiol Rev, 77, pp. 51-74.
39. Saksela, O. and Rifkin, D. B. (1988) Cell-associated plasminogen activation: Regulation and physiological functions. Annu Rev Cell Biol, 4, pp. 93-126.
40. Juhan-Vague, I. and Alessi, M. C. (1993) Plasminogen activator inhibitor 1 and atherothrombosis. Thromb Haemost, 70, pp. 138-143.
41. Thompson, S. G., Kienast, J., Pyke, S. D., Haverkate, F. and van de Loo, J. C. (1995) Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med, 332, pp. 635-641.
42. Bloor, C. M., Nimmo, L., McKirnan, M. D., Zhang, Y. and White, F. C. (1997) Increased gene expression of plasminogen activators and inhibitors in left ventricular hypertrophy. Mol Cell Biochem, 176, pp. 265-271.